Unfortunately, the oral administration of these molecules, which are able to strongly activate PPARγ, provoked unwanted side effects at the same time (weight gain, fluid retention, osteoporosis, cardiovascular diseases, and bladder cancer) [43,44,45,46]. Here, PPARG is linked to cardiovascular disorder.